Beta-Thalassemia
Overview and clinical definition are open. Full Step 1 details unlock with a plan.
For the why behind the fact
Use this page to connect what you are memorizing.
Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.
Overview
Plain-Language Overview
Beta-Thalassemia is a genetic blood disorder that affects the body's ability to produce enough healthy red blood cells. It primarily involves the blood and bone marrow, where red blood cells are made. People with this condition have a problem with the beta-globin chains of hemoglobin, the protein that carries oxygen in the blood. This leads to anemia, which means the body does not get enough oxygen, causing symptoms like fatigue, weakness, and pale skin. The disorder can range from mild to severe, and in serious cases, it may require regular blood transfusions. It mainly affects people from Mediterranean, Middle Eastern, and Southeast Asian backgrounds. Managing the condition often involves monitoring and treating complications related to low red blood cell counts.
Clinical Definition
Beta-thalassemia is reduced (beta-plus) or absent (beta-zero) beta-globin synthesis from HBB variants, usually point/splice/regulatory changes. Unpaired alpha chains injure erythroid precursors and circulating cells, causing ineffective erythropoiesis and hemolysis. The spectrum includes trait, non-transfusion-dependent disease and transfusion-dependent disease; genotype and modifiers matter beyond simply counting affected alleles. Severe forms cause microcytic anemia, marrow expansion and iron overload; trait is usually mild.